El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

704857.pdf (779.8 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-03-30

Llicència de publicació

cc-by (c) Osella Abate, Simone et al., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176347

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3390/cancers11040452

Resum

Survival predictions are currently determined on the basis of NRAS/BRAF mutations, even though TERT promoter mutations have been recently associated with a poor prognosis in stage I-II melanomas. Usually, it is not recommended to perform a mutational test on primary melanoma, as the results do not always reflect the mutational status of metastases. In particular, trunk melanomas have been reported to have an unfavourable prognosis. A series of 105 advanced melanoma patients were analysed by TERT promoter Sanger sequencing. Univariate/multivariate binary logistic regression models were performed using progression to a visceral site as the dependent variable and patient/tumour characteristics as covariates. Performance of the model was assessed in an external independent primary melanoma patients' dataset. Male gender (odds ratio (OR), 344; 95% CI, 1.12⁻10.6; p = 0.031), AJCC (American Joint Committee on Cancer) classification (OR, 022; 95% CI, 0.07⁻0.67; p = 0.008), SLNB (Sentinel Lymph Node Biopsy) status (OR, 3.05; 95% CI, 1.06⁻8.78; p = 0.039) and TERT-mutated trunk lesions (OR, 3.78; 95% CI, 1.35⁻10.6; p = 0.011) were significantly associated with the risk of developing a visceral spreading as first site of progression using multivariate logistic regression analysis. These results were confirmed in the external validation control group. Therefore, in trunk primary melanomas, due to their high risk of progression to visceral sites, we encourage somatic TERT mutation analysis at diagnosis to identify those patients who would potentially benefit from a more intensive follow-up protocol and a prompt initiation of therapy.

Matèries

Melanoma, Metàstasi, Mutació (Biologia)

Matèries (anglès)

Melanoma, Metastasis, Mutation (Biology)

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

OSELLA ABATE, Simone, BERTERO, Luca, SENETTA, Rebecca, MARIANI, Sara, LISA, Francesco, COPPOLA, Vittoria, METOVIC, Jasna, PASINI, Barbara, PUIG I SARDÀ, Susana, FIERRO, Maria teresa, MANRIQUE SILVA, Esperanza, KUMAR, Rajiv, NAGORE, Eduardo, CASSONI, Paola, RIBERO, Simone. TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk. _Cancers_. 2019. Vol. 11, núm. 4, pàgs. 452. [consulta: 25 de desembre de 2025]. ISSN: 2072-6694. [Disponible a: https://hdl.handle.net/2445/176347]

Exportar metadades

JSON - METS

Compartir registre